Selective blockade of the NOX2 isoform protects the retina and suggests that GLX7013170, as a neuroprotectant and anti-inflammatory agent and a potential therapeutic of retinal diseases, including the early stage of diabetic retinopathy. Here, CYBB is linked to Abnormal retinal morphology.